Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC with oxaliplatin for colorectal peritoneal metastasis
jRCTs031260298Recruiting
- Sponsor
- Japan Institute for Health Security
- Start
- Aug 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxaliplatin in colorectal cancer (CRC) and appendiceal cancer, sponsored by Japan Institute for Health Security. Primary endpoint: Treatment completion rate. Started Aug 2026; status: recruiting.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)appendiceal cancer
Beyond the preview
Go deeper on jRCTs031260298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031260298.